Jahn M. Nesland - Concepedia

Author

Jahn M. Nesland

Also Known As

J M Nesland, J NESLAND, J. M. NESLAND, J. M. Nesland, J.M Nesland, J.M. NESLAND, J.M. Nesland, JAHN M. NESLAND, Jahn M Nesland, Jahn M. NESLAND

247

Publications

14.5K

Citations

H-Index

124

Concepts

All Affiliations

University of Oslo Norwegian Cancer Society Oslo University Hospital First Affiliated Hospital of Zhengzhou University Zhengzhou University

About

Jahn M. Nesland is an author at University of Oslo specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	85	7.6K
2	Health Sciences	12	12	637
3	Engineering	3	3	64
4	Natural Sciences	2	2	86
5	Public Health	2	2	89

Jahn M. Nesland

166

Publications

12.8K

Citations

H-Index

Page 1

	Year	Citations
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis Jiřina Bártková, Zuzana Hořejšı́, Karen Koed, Nature ChromatinTumor BiologyGenome InstabilityDna DamageOncogenic Agent	2005	2.7K
Morphologic Reappraisal of Serrated Colorectal Polyps Emina Torlakovic, Eva Skovlund, Dale C. Snover, The American Journal of Surgical Pathology Serrated PolypsSerrated AdenomaMedicineSurgical PathologyHistopathology	2003	614
Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients Vera M. Abeler, Odd Røyne, Steinar Thoresen, Histopathology	2009	430
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer Tuan Zea Tan, Qing Hao Miow, Ruby Yun‐Ju Huang, EMBO Molecular Medicine	2013	287
Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer Ingvil Sæterdal, Jens Bjørheim, Kari Lislerud, Proceedings of the National Academy of Sciences	2001	266
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells Elin Borgen, Bjørn Naume, Jahn M. Nesland, Cytotherapy Immunostained CellsImmunocytochemical TechniqueOncologyObjective CriteriaMedicine	1999	265
EGFR family expression in breast carcinomas. c‐erbB‐2 and c‐erbB‐4 receptors have different effects on survival Zhenhe Suo, Bjørn Risberg, Mats G. Kalsson, The Journal of Pathology	2001	213
Re-expression of E-cadherin, ?-catenin and ?-catenin, but not of ?-catenin, in metastatic tissue from breast cancer patients I. K. Bukholm, Jahn M. Nesland, Anne-Lise B√∏rresen-Dale The Journal of Pathology	2000	207
Over-expression of cyclin a is highly associated with early relapse and reduced survival in patients with primary breast carcinomas Ida Bukholm, Geir Bukholm, Jahn M. Nesland International Journal of Cancer Cyclins ABreast OncologyMedicinePrimary Breast CarcinomasReduced Survival	2001	205
Differentiation of Human Embryonal Carcinomas <i>In vitro</i> and <i>In vivo</i> Reveals Expression Profiles Relevant to Normal Development Rolf I. Skotheim, Guro E. Lind, Outi Monni, Cancer Research	2005	198

Page 1